BSE filing, NSE: CSURGSU. Summary written from the filing by ALFA Finder's alert engine.
Centenial Surgical Suture Ltd: key numbers
- Share price
- ₹71.25
- Market cap
- ₹25.99 Cr
- Revenue (annual)
- ₹53.84 Cr
- Net profit (annual)
- ₹-2.20 Cr
- P/E (TTM)
- -18.0×Sector 52.0×
- Promoter holding
- 46.89%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Centenial Surgical Suture Ltd
All →Centenial Surgical Suture Other Announcement
Centenial Surgical Suture Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI listing regulations.
Centenial Surgical Suture Price Movement Clarification
Centenial Surgical Sute reports abnormal share-price movement unsupported by any corporate news and requests BSE/SEBI investigation into suspected manipulative trades. The company states no material announcement explains the unusual price action.
Centenial Surgical Suture Management Change
Anuradha Kashikar has resigned from her position as Executive Director and Key Managerial Personnel (KMP) of Centenial Surgical Suture Ltd, effective October 5, 2026.
Centenial Surgical Suture Annual General Meeting
Centenial Surgical Suture Ltd announced results for its Annual General Meeting held on September 28, 2026. All three resolutions were passed with the requisite majority.
Centenial Surgical Suture Management Change
Centenial Surgical Suture Ltd has appointed Ms. Sapna Mhatre as Chief Financial Officer, succeeding Ms. Anuradha Kashikar, who resigned from the position effective August 14, 2026.
Centenial Surgical Suture Annual Report
Centenial Surgical Suture Ltd has filed its 31st Annual Report for the financial year 2025-2026 as per SEBI (LODR) Regulations.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.